Ventana FITC Anti-Fibrinogen Primary Antibody - HSA Registration DE0509389
Access comprehensive regulatory information for Ventana FITC Anti-Fibrinogen Primary Antibody in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0509389 and owned by Ventana Medical Systems, Inc.. The device was registered on June 12, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
FITC Anti-Fibrinogen Primary Antibody is a polyclonal antibody labeled with fluorescein. It is intended for laboratory use in the qualitative immunofluorescent detection of fibrinogen by fluorescence microscopy in sections of frozen tissue stained on a BenchMark IHC/ISH instrument. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.